FDA, EMEA to jointly review genomic data

FDA and EMEA agreed to hold joint briefing meetings to review companies' voluntary submissions of genomic data. FDA's Interdisciplinary Pharmacogenomics Review Group and EMEA's Pharmacogenetics Workin...